Edgewise Therapeutics, Inc. (EWTX)

28.61 -1.17 (-3.93%) USD  |  NASDAQ  |  Jan 23, 16:00
28.06 -0.55 (-1.92%) After-Hours: 20:00
More

Edgewise Therapeutics Research and Development Expense (TTM): 142.03M for Sept. 30, 2025

Research and Development Expense (TTM) Chart

View Research and Development Expense (TTM) for EWTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Dynavax Technologies Corp. 73.78M
Omeros Corp. 84.14M
Gilead Sciences, Inc. 5.734B
Agios Pharmaceuticals, Inc. 329.01M
NovaBay Pharmaceuticals, Inc. --